The bioprocess integrity testing systems market is projected to grow from USD 87.6 USD million in 2025 to USD 152.5 USD million by 2035, at a CAGR of 5.7%. Non-Destructive Testing will dominate with a 53.7% market share, while particle-based will lead the process types segment with a 58.4% share.